Linkage Projects - Grant ID: LP0221344

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0221344

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Engineering of anti-platelet antibodies for the diagnosis and therapy of infants with bleeding disorders. Foeto-maternal alloimmune thrombocytopenia (FMAIT) is a serious clinical condition where infants suffer potentially fatal bleeding disorders from 14 weeks gestation to 1-2 weeks post delivery. The cause of the disease is through maternal antibodies destroying foetal platelets. Our aim is to produce human antibodies, which will be used as diagnostic agents to screen for the condition in pregnant women, and to further develop such antibodies for therapy. Identification of mothers at risk of FMAIT and the development of a specific therapy are vital to the management and prevention of this serious condition.

Funded Activity Details

Start Date: 29-05-2002

End Date: 30-05-2006

Funding Scheme: Linkage Projects

Funding Amount: $67,635.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Agricultural Biotechnology | Diagnostic Applications | Genetic Engineering And Enzyme Technology | Immunology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

Diagnostics | Treatments (e.g. chemicals, antibiotics) |

Other Keywords

Agricultural Biotechnology | Diagnostic Applications | Diagnostics | Genetic Engineering And Enzyme Technology | Immunology Not Elsewhere Classified | Treatments (e.g. chemicals, antibiotics)

Related Links